DAMASCUS, MD
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)SARCOMA FOUNDATION OF AMERICA, founded in 2000, is a community nonprofit in the Arts, Culture & Humanities sector that reported $3.5M in total revenue in fiscal year 2024. Net assets of $11.0M represent 37 months of operating reserves.
THE MISSION OF THE ORGANIZATION IS TO ADVOCATE FOR SARCOMA PATIENTS BY FUNDING RESEARCH AND BY INCREASING AWARENESS ABOUT THE DISEASE. THE ORGANIZATION RAISES MONEY TO PRIVATELY FUND GRANTS FOR SARCOMA RESEARCHERS AND CONDUCTS EDUCATION AND ADVOCACY EFFORTS ON BEHALF OF SARCOMA PATIENTS.
THE SARCOMA FOUNDATION OF AMERICA (SFA) COORDINATES A NATIONAL RESEARCH GRANT PROGRAM THAT FUNDS TRANSLATIONAL SCIENCE SARCOMA RESEARCH. IN ACCORDANCE WITH THE MISSION OF THE SFA, RESEARCH INVOLVING...
THE SARCOMA FOUNDATION OF AMERICA (SFA) COORDINATES A NATIONAL RESEARCH GRANT PROGRAM THAT FUNDS TRANSLATIONAL SCIENCE SARCOMA RESEARCH. IN ACCORDANCE WITH THE MISSION OF THE SFA, RESEARCH INVOLVING THE DEVELOPMENT OF NOVEL AGENTS AGAINST SARCOMA, OR RESEARCH THAT COULD POTENTIALLY LEAD TO THE DEVELOPMENT OF NOVEL AGENTS AGAINST SARCOMA, IS SUPPORTED THROUGH THIS FUNDING. THE SFA ENGAGES IN PATIENT EDUCATION PROGRAMS ON THE LATEST DEVELOPMENTS IN SARCOMA RESEARCH AND TREATMENTS. THESE EDUCATION INITIATIVES ARE DESIGNED TO FURTHER STRENGTHEN AND DEEPEN PATIENTS' ABILITY TO PARTICIPATE IN THEIR CARE AND RESEARCH PROJECTS. SFA ALSO CONDUCTS ADVOCACY ACTIVITIES ON BEHALF OF THE SARCOMA COMMUNITY TO ENSURE ADEQUATE FEDERAL CANCER RESEARCH FUNDING LEVELS AND POLICIES THAT POSITIVELY IMPACT SARCOMA PATIENTS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $3,547,902 | $3,709,252 | 0.0% |
| Expenses | $3,570,622 | $3,222,438 | +0.1% |
| Net Income | $-22,720 | $486,814 | -1.0% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MARK THORNTON MD PHD | PRESIDENT | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| JOHN SJ BROOKS MD | VICE PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| PATRICIA THORNTON | TREASURER | 3.00 |
Officer
Director
|
$0 | $0 | $0 |
| CHRISTOPHER CONNERY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL LEWIS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JUSTIN GREEN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BRUCE MARCH | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JENNIFER GOODWIN | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JENNIFER NELLANY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BRANDI CLEARY-FELSER | CEO | 40.00 |
Officer
|
$219,241 | $22,049 | $241,290 |
| DEAN FROHLICH | DIRECTOR OF SCIENTIFIC AFFAIRS | 40.00 |
Highest
|
$152,541 | $14,964 | $167,505 |
| ANNIE BLAKE | NATIONAL DIRECTOR, RTCS | 40.00 |
Highest
|
$104,885 | $17,335 | $122,220 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $3,547,902 | $3,570,622 | $11,423,128 | $-22,720 |
| 2023 | $3,709,252 | $3,222,438 | $11,153,810 | $486,814 |
| 2022 | $3,674,023 | $2,690,137 | $9,805,602 | $983,886 |
| 2021 | $3,973,362 | $2,396,561 | $9,642,356 | $1,576,801 |
| 2020 | $2,719,131 | $1,993,762 | $7,850,855 | $725,369 |
| 2019 | $3,308,423 | $3,171,547 | $7,375,324 | $136,876 |
| 2018 | $2,942,268 | $2,647,890 | $6,491,558 | $294,378 |
Compare SARCOMA FOUNDATION OF AMERICA with other nonprofits in Maryland and across the country.